Arcam receives order from European research institute

Regulatory News:

Arcam, listed on NASDAQ OMX, has received an order for an EBM system from a research institute in Europe. The system will be shipped in 2014.

"This new order follows on the three orders we presented last week. With the present order intake and business situation we will have a solid order book going into 2014”, says Magnus René, CEO of Arcam.

The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published on October 28, 2013.

Arcam provides a cost-efficient Additive Manufacturing solution for production of metal components. The technology offers freedom in design combined with excellent material properties and high productivity. Arcam’s market is global with customers mainly in the orthopedic and aerospace industries. The company was founded in 1997 and is listed on NASDAQ OMX Stockholm, Sweden. Head office and production facilities are located in Mölndal, Sweden. Support offices are located in the US, UK, Italy and China.

This information was brought to you by Cision http://news.cision.com